Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Discover
Back to filter
Show all topics (10)
Related topics
High quality Bioluminescence and X-Ray analysis in lung squamous cell carcinoma
Jul 21, 2021
Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence,...
Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility
Jul 15, 2021
6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full...
ACCELA webinar recording : IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jul 15, 2021
Intravital microscopy can visualize...
Webinar recording: Autofluorescence management - the power of Spectral Flow Cytometry
Jul 15, 2021
One of the key advantages of spectral flow cytometry is its ability to extract sample...
Webinar recording: Super-Resolution imaging of Chromatin organization in health and disease
Jul 9, 2021
Understanding how cells organize the array of components within their membranous confines can not only provide insight...
Jul 8, 2021
NanoView Biosciences has developed...
Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles
Jul 3, 2021
Overactivation of the PI3K/mTOR signaling has been identified in non-Hodgkin’s lymphoma....
Quantitative two-photon microscopy imaging analysis of human skin
Jul 1, 2021
Transdermal skin delivery is a method to transport various topical formulations to a deeper skin layer non-invasively....
OMIXYS Educational webinar series: IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jun 11, 2021
Intravital microscopy can visualize...
Jun 10, 2021
NanoView Biosciences has developed...
Registering FDG/PET mouse and AMYViD/PET-CT rat studies to brain VOI atlases
May 22, 2018
Preclinical NeuroPET is employed widely in studies of stroke, ischemia, addiction and neurodegenerative diseases. A wide range of tracers are used in NeuroPET studies. In both clinical and preclinical imaging, 18FDG is frequently used as a biomarker of brain function in models of neurological disorders. Targeted tracers such as the recently FDA approved Florbetapir F18 (AMYViD) amyloid tracer provide specific activity. Additionally, using both post synaptic and pre synaptic specific tracers, researchers can make in vivo measurements of neurotransmitter function.
Do you want to learn more? Read the whole article!
Brand profile
